๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Blastic mantle cell lymphoma developing concurrently in a patient with chronic myelogenous leukemia and a review of the literature

โœ Scribed by Eve Rodler; Jeanna Welborn; Sandra Hatcher; Katherine Unger; Edward Larkin; Paul H. Gumerlock; Theodore Wun; Carol Richman


Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
171 KB
Volume
75
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Hydroxyurea-Induced gangrene of the toes
โœ Yasuda, Norimasa; Ohmori, Sei-ichi; Usui, Tadao ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 148 KB ๐Ÿ‘ 1 views

To the Editor: Semenzato et al. proposed new criteria for large granular lymphocyte (LGL) leukemia because patients with low levels of GL were similar to those with levels greater than 2,000 GL/l [1]. LGL leukemia is a GL proliferative disease often accompanied by pure red cell aplasia (PRCA). T-cel

Complete hematologic and cytogenetic res
โœ Alvaro Aguayo; Jorge E. Cortes; Hagop M. Kantarjian; Miloslav Beran; Varsha Gand ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 97 KB ๐Ÿ‘ 1 views

## BACKGROUND. T-cell lymphoid blastic phase (BP) transformation is rare in chronic myelogenous leukemia (CML). 2-amino-9-โค-D-arabinosyl-6-methoxy-9H-guanine (GW506U78), a prodrug of arabinosylguanine (ara-G), is effective in T-cell leukemias. ## METHODS. The authors present a case of a 48-year